Information Journal Paper
APA:
CopyLEE, M., MCGEER, E., & KODELA, R.. (2013). NOSH-ASPIRIN (NBS- 1120), A NOVEL NITRIC OXIDE AND HYDROGEN SULFIDE RELEASING HYBRID, ATTENUATES NEUROINFLAMMATION INDUCED BY MICROGLIAL AND ASTROCYTIC ACTIVATION: A NEW CANDIDATE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS. GLIA, 61(-), 1724-1734. SID. https://sid.ir/paper/682861/en
Vancouver:
CopyLEE M., MCGEER E., KODELA R.. NOSH-ASPIRIN (NBS- 1120), A NOVEL NITRIC OXIDE AND HYDROGEN SULFIDE RELEASING HYBRID, ATTENUATES NEUROINFLAMMATION INDUCED BY MICROGLIAL AND ASTROCYTIC ACTIVATION: A NEW CANDIDATE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS. GLIA[Internet]. 2013;61(-):1724-1734. Available from: https://sid.ir/paper/682861/en
IEEE:
CopyM. LEE, E. MCGEER, and R. KODELA, “NOSH-ASPIRIN (NBS- 1120), A NOVEL NITRIC OXIDE AND HYDROGEN SULFIDE RELEASING HYBRID, ATTENUATES NEUROINFLAMMATION INDUCED BY MICROGLIAL AND ASTROCYTIC ACTIVATION: A NEW CANDIDATE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS,” GLIA, vol. 61, no. -, pp. 1724–1734, 2013, [Online]. Available: https://sid.ir/paper/682861/en